Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4781451
Max Phase: Preclinical
Molecular Formula: C57H80N8O14S2
Molecular Weight: 1165.44
Molecule Type: Unknown
Associated Items:
ID: ALA4781451
Max Phase: Preclinical
Molecular Formula: C57H80N8O14S2
Molecular Weight: 1165.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)C(C)C)cc1
Standard InChI: InChI=1S/C57H80N8O14S2/c1-36(2)49(55(72)64-30-43(66)26-45(64)53(70)58-28-39-8-12-41(13-9-39)50-37(3)60-34-80-50)62-47(68)32-78-24-22-76-20-18-74-16-17-75-19-21-77-23-25-79-33-48(69)63-52(57(5,6)7)56(73)65-31-44(67)27-46(65)54(71)59-29-40-10-14-42(15-11-40)51-38(4)61-35-81-51/h8-15,34-36,43-46,49,52,66-67H,16-33H2,1-7H3,(H,58,70)(H,59,71)(H,62,68)(H,63,69)/t43-,44-,45+,46+,49+,52-/m1/s1
Standard InChI Key: MYKUZIAADLKQLR-ZVOHJLPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1165.44 | Molecular Weight (Monoisotopic): 1164.5235 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Girardini M,Maniaci C,Hughes SJ,Testa A,Ciulli A. (2019) Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs., 27 (12.0): [PMID:30826187] [10.1016/j.bmc.2019.02.048] |
Source(1):